RauJL. The inhalation of drugs: advantages and problems. Respir Care, 2005; 50(3):367–382.
2.
RauJL, AriA, RestrepoRD. Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care, 2004; 49(2):174–179.
3.
SangwanS, CondosR, SmaldoneGC. Lung deposition and respirable mass during wet nebulization. J Aerosol Med, 2003; 16(4):379–386.
4.
HaynesJM. Randomized controlled trial of a breath-activated nebulizer in patients with exacerbation of COPD. Respir Care, 2012; 57(9):1385–1390.
5.
RuppelGL. What is the clinical value of lung volumes?. Respir Care, 2012; 57(1):26–35.
6.
Puente-MaestuL, StringerWW. Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis, 2006; 1(4):381–400.
7.
MahlerDA. Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2006; 3(3):234–238.
8.
ArunthariV, BruinsmaRS, LeeAS, JohnsonMM. A prospective, comparative trial of standard and breath-actuated nebulizer: efficacy, safety, and satisfaction. Respir Care, 2012; 57(8):1242–1247.
